Searched for
TREATMENT OPTIONS
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...- The accounting trick used by companies to make a weak balance sheet look strongIn one recent case, a large investment sat comfortably under equity until the auditor read the shareholders' agreement, found a buyback cla...
- ₹50 lakh to ₹1.4 crore: How extending your PPF can add lakhs to your corpus and who should do itPPF maturity presents a choice: withdraw or extend for continued tax-free compounding. While government backing and tax benefits remain att...
- VC contract terms get tougher on founder shares after governance lapsesVenture capital firms are tightening founder contracts, with nearly 76% of Indian startups now allowing the forfeiture of vested shares for...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- RBI issues draft CCR framework aligned with global standardsThe Reserve Bank of India has released draft rules for banks. These rules cover how banks calculate risks from derivative deals. They also ...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- Texas big medical boost: Nvidia billionaire Tench Coxe, wife Simone donate $100 million to UT Austin healthcare projectNvidia board member Tench Coxe and his wife Simone Coxe have donated $100 million for a new medical center in Austin, Texas. This significa...
- Germany student health insurance guide: Eligibility, costs and coverageGermany mandates health insurance for all international students seeking university admission. Students can choose between public or privat...
- This blood test may reveal lung cancer risk long before symptomsA new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....
- American proverb of the day: 'Never make someone a priority when all you are to them is an option.' Lessons on self-respect & emotional well-beingAmerican Proverb of the Day: The proverb "Never make someone a priority when all you are to them is an option" highlights the importance of...
- PE wars to billion-dollar IPO dreams, hospital sector is fighting fitMajor private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...
- Anushka Sharma gets called out by The Liver Doc for promoting ‘witchcraft’ homeopathy: ‘She is irrational…’Actress Anushka Sharma's Instagram post praising homeopathy has ignited a fierce debate. She shared her positive experiences with the alter...
- Travel insurance versus overseas student health cover: What Indian students need to knowIndian students studying in Australia must secure Overseas Student Health Cover (OSHC) for visa compliance and medical needs. While not man...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Thailand travel may get costlier for foreign tourists. Here's whyThailand is reviewing its planned foreign tourist entry fee, potentially increasing it beyond 300 baht due to rising insurance and healthca...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
Load More
